Dr. Bruce Bowers, M.D.

Claim this profile

Medical City Dallas

Studies Mitral Regurgitation
Studies Mitral Valve Regurgitation
3 reported clinical trials
6 drugs studied

Affiliated Hospitals

Image of trial facility.
Medical City Dallas
Image of trial facility.
Medical City Dallas Hospital

Clinical Trials Bruce Bowers, M.D. is currently running

Image of trial facility.

Transcatheter Valve Repair

for Mitral Regurgitation

This trial tests a new device called Edwards PASCAL that fixes leaky heart valves without surgery. It is for patients who can't have surgery or haven't improved with other treatments. The device helps the valve close better, stopping blood from leaking backward.
Recruiting1 award N/A9 criteria
Image of trial facility.

Tendyne Transcatheter Mitral Valve System

for Mitral Regurgitation

Prospective, controlled, multicenter clinical investigation with four trial cohorts: Randomized, Non-repairable, Severe Mitral Annular Calcification (MAC) and Severe Mitral Annular Calcification Continued Access Protocol (MAC CAP). Subjects in the Randomized cohort will be randomized in a 1:1 ratio to the trial device or to the MitraClip system. Subjects in the Non-repairable, Severe MAC, and Severe MAC CAP cohorts will receive the trial device. The objective of the Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation (SUMMIT) is to evaluate the safety and effectiveness of the Tendyne Transcatheter Mitral Valve System for the treatment of patients with symptomatic, moderate-to-severe or severe mitral regurgitation or for patients with symptomatic mitral valve disease due to severe mitral annular calcification. This randomized controlled trial will provide the opportunity to evaluate the safety and clinical benefits of the Tendyne Transcatheter Mitral Valve System compared to the MitraClip System in patients with symptomatic, moderate-to-severe or severe mitral regurgitation, within approved MitraClip indications. In addition, the safety and effectiveness of the Tendyne Transcatheter Mitral Valve System will be evaluated in patients with severe mitral annular calcification who are at prohibitive risk for mitral valve surgery. Patients who are not suitable for mitral valve surgery for reasons other than severe mitral annular calcification and are also not suitable for transcatheter repair with MitraClip, will be enrolled in the Non-repairable cohort. Subjects will be seen at screening, pre- and post-procedure, discharge, 30 days, 3 months, 6 months, and annually through 5 years.
Recruiting1 award N/A4 criteria

More about Bruce Bowers, M.D.

Clinical Trial Related7 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Bruce Bowers, M.D. has experience with
  • MitraClip System
  • Tendyne Mitral Valve System
  • Abbott Mitraclip System
  • Edwards PASCAL System
  • Evolut FX TAVR System
  • Medtronic Evolut PRO+ TAVR System

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Bruce Bowers, M.D. specialize in?
Is Bruce Bowers, M.D. currently recruiting for clinical trials?
Are there any treatments that Bruce Bowers, M.D. has studied deeply?
What is the best way to schedule an appointment with Bruce Bowers, M.D.?
What is the office address of Bruce Bowers, M.D.?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security